Lupin’s arm recalls Morphine Sulfate extended-release tablets in US

06 May 2019 Evaluate

Lupin’s subsidiary -- Novel Laboratories’ Somerset facility is recalling 46,700 bottles of Morphine Sulfate extended-release tablets, used to treat severe pain, in the US market. The recalling is in various strengths due to failed impurities/degradation specifications.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2315.40 -19.55 (-0.84%)
30-Mar-2026 15:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1765.40
Dr. Reddys Lab 1255.50
Cipla 1227.70
Zydus Lifesciences 872.45
Lupin 2315.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×